For instance, in a mouse melanoma model, ablation of tumour-intrinsic NF-κB activity using cancer cell-targeted expression of an IκBα super-repressor construct led to cytotoxicity-driven tumour regression following doxorubicin treatment [224]. The gene discussed is NFKB1; the disease is cancer.